Value and Sustainability of Semi-reusable Patch Pump Therapy in Routine Care: A Prospective Multicentre Study
Authors' conclusion
In routine care, a semi-reusable tubeless pump maintained glycaemic control while reducing hypoglycaemia and disposable costs versus fully disposable patch pumps, with measurable reductions in electronic waste. These data support value-based, sustainable diabetes technology adoption.
Study context
- Population
- Adults with T1D or T2D transitioning from continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI) to a semi-reusable tubeless insulin pump (Microtech Equil™), routine carecompleted follow-up
- Participants
- 97 adults
- Exposure
- Semi-reusable tubeless insulin pump after transition from CSII or MDI
- CSIIn = 79
- MDIn = 18
- Outcome
- HbA1c non-inferiority and change in hypoglycaemic event frequency
- Follow-up
- 3 months
Methodological detailsmulticentre, open-label, real-world
- Multicentre
- Open-label
- Real-world
Main finding
As reported in the abstract
HbA1c non-inferiority; hypoglycaemic events
Decrease in hypoglycaemic events, CSII
45%
Decrease in hypoglycaemic events, MDI
86%
Observational data: associations, not effects.
Secondary outcomes
Mean monthly disposable treatment costs, participants previously using fully disposable tubeless pumps
- Decrease in mean monthly disposable treatment costs (p < 0.001)
- €108.6
Waste
- Semi-reusable architecture eliminated routine disposal of batteries/electronic components and reduced overall waste
Safety
Device-related adverse events
- Device-related AEs were infrequent and mainly mild
Original publication
Value and Sustainability of Semi-reusable Patch Pump Therapy in Routine Care: A Prospective Multicentre Study. J Diabetes Sci Technol. Published 31 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →